The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable income are the major factors driving the growth of this market. On the other hand, stringent regulatory and clinical processes are expected to restrain market growth to a certain extent.
The global dental biomaterial market is consolidated at the top with the presence few big players in the market. However, there are many local, regional, and global players operating in this market, making it highly competitive. Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland) were the major players in this market. The companies are mainly focusing on acquisitions and agreements & collaborations to strengthen their market presence.
To know about the assumptions considered for the study download the pdf brochure
The bone graft substitute market is the largest product segment in the dental biomaterials market and the leaders in of the bone graft substitute are mentioned below:
Geistlich Pharma AG (Switzerland) is a market leader in the dental bone graft substitute market. The company focuses on developing and manufacturing new products for regenerative medicine. Over the past three years, the company has adopted organic growth strategies, such as product development and launches and expansions to enhance its market presence. For example, it recently improved its presence in Japan by launching the Bio-Gide (dental bone graft) in the market. In 2017, Geistlich also opened its tenth subsidiary, in India. This marked Geistlich’s entry into a potential emerging market for regenerative dentistry.
Zimmer Dental Inc. (US) stood second in the dental bone graft substitute market. The company is a provider of dental oral rehabilitation products and is a subsidiary of Zimmer Holdings, Inc. The company adopted expansions and acquisitions as key strategies for growth in the market over the last three years. In 2015, Zimmer Holdings, Inc. acquired the company, Biomet Inc which helped it expand its dental biomaterials business. In 2017, Zimmer Biomet Holdings, Inc. reopened its dental division’s Zimmer Biomet Institute training center in Parsippany, New Jersey (US). This facility provides educational courses to dental clinicians around the world that are interested in restorative, surgical, and regenerative procedures.
Dentsply Sirona Inc. (US) is one of the leading providers of dental products. The company adopted acquisitions, new product launches, and agreements as its key growth strategies. For example, in February 2016, the company merged with DENTSPLY International Inc. This merger enabled the company in expanding its business and product offerings in the dental biomaterials market.
Related Reports:
Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User - Global Forecast to 2023
Know more about Dental Biomaterials Market Growth -
https://www.marketsandmarkets.com/PressReleases/dental-biomaterial.asp
